BANK OF AMERICA CORP /DE/
BankPosition in FENC — Fennec Pharmaceuticals Inc.
CIK 70858
CHARLOTTE, NC
Position in FENC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$214,376
+$51,986 QoQ
Shares Held
19,942
-24.5% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 104 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FENC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. FENC ranks #285 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in FENC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $214,376 | 19,942 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $162,390 | 26,405 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $173,502 | 22,533 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $125,825 | 13,443 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $159,001 | 19,157 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $136,445 | 22,405 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $226,426 | 35,827 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $135,620 | 27,124 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $161,535 | 26,438 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $183,246 | 16,479 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $449,416 | 40,055 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $238,343 | 31,737 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $201,606 | 22,832 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $56,034 | 6,735 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $21,120 | 2,200 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $21,222 | 2,620 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $27,682 | 4,961 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $27,781 | 4,961 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $50,085 | 11,383 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $45,658 | 4,847 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $32,476 | 4,455 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $208,699 | 33,607 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $150,564 | 20,210 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $125,459 | 20,703 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $305,225 | 36,554 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $51,511 | 8,672 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||